Geneos Wealth Management Inc. Has $156,000 Stake in CME Group Inc. (NASDAQ:CME)

Geneos Wealth Management Inc. reduced its position in shares of CME Group Inc. (NASDAQ:CME) by 27.9% in the 4th quarter, Holdings Channel reports. The institutional investor owned 741 shares of the financial services provider’s stock after selling 287 shares during the quarter. Geneos Wealth Management Inc.’s holdings in CME Group were worth $156,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the company. Geode Capital Management LLC grew its stake in shares of CME Group by 1.6% during the 1st quarter. Geode Capital Management LLC now owns 7,085,300 shares of the financial services provider’s stock worth $1,355,370,000 after acquiring an additional 108,740 shares in the last quarter. Bank of New York Mellon Corp grew its position in CME Group by 0.5% in the third quarter. Bank of New York Mellon Corp now owns 6,913,562 shares of the financial services provider’s stock valued at $1,224,597,000 after purchasing an additional 31,354 shares in the last quarter. Morgan Stanley increased its stake in CME Group by 31.5% in the 3rd quarter. Morgan Stanley now owns 4,858,967 shares of the financial services provider’s stock valued at $972,863,000 after buying an additional 1,163,103 shares during the last quarter. FMR LLC lifted its position in CME Group by 1.8% during the 3rd quarter. FMR LLC now owns 4,029,771 shares of the financial services provider’s stock worth $806,841,000 after buying an additional 70,588 shares in the last quarter. Finally, Vontobel Asset Management Inc. boosted its stake in shares of CME Group by 3.5% during the 1st quarter. Vontobel Asset Management Inc. now owns 3,962,053 shares of the financial services provider’s stock worth $814,270,000 after buying an additional 133,897 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

CME has been the topic of a number of recent research reports. Keefe, Bruyette & Woods reaffirmed a “market perform” rating and issued a $229.00 target price on shares of CME Group in a research report on Wednesday, April 3rd. Morgan Stanley upped their price objective on CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 9th. Rosenblatt Securities reissued a “sell” rating and issued a $180.00 price objective on shares of CME Group in a report on Thursday, January 4th. Argus increased their price target on shares of CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a research note on Wednesday, March 6th. Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $210.00 price objective (down from $235.00) on shares of CME Group in a research note on Friday, April 5th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $215.70.

CME Group Stock Performance

NASDAQ CME opened at $209.50 on Monday. The stock has a market cap of $75.42 billion, a PE ratio of 23.62, a P/E/G ratio of 5.95 and a beta of 0.49. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a 50-day moving average of $213.98 and a 200-day moving average of $211.57. CME Group Inc. has a 52-week low of $175.73 and a 52-week high of $223.80.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, February 14th. The financial services provider reported $2.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.10. CME Group had a net margin of 57.83% and a return on equity of 12.32%. The firm had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.43 billion. During the same period last year, the business posted $1.92 earnings per share. The business’s revenue for the quarter was up 19.2% compared to the same quarter last year. On average, sell-side analysts anticipate that CME Group Inc. will post 9.56 EPS for the current year.

CME Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 26th. Shareholders of record on Friday, March 8th were given a dividend of $1.15 per share. This is a boost from CME Group’s previous quarterly dividend of $1.10. The ex-dividend date of this dividend was Thursday, March 7th. This represents a $4.60 annualized dividend and a yield of 2.20%. CME Group’s dividend payout ratio (DPR) is presently 51.86%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.